Octreotide treatment in patients with necrotizing pancreatitis and pulmonary failure

Intensive Care Medicine

Volumn 22, Issue 9, 1996, Pages 909-915

  Fiedler, F ^a   Jauernig, G ^a   Keim, V ^b   Richter, A ^c   Bender, H J ^a  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acute pancreatitis; ARDS; Circulatory shock; Necrotizing pancreatitis; Octreotide; SIRS; Systemic complications; Treatment

Indexed keywords

HYPOTHALAMUS RELEASE INHIBITING FACTOR; OCTREOTIDE;

ACUTE HEMORRHAGIC PANCREATITIS; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG INSUFFICIENCY; MORTALITY; PROSPECTIVE STUDY; SHOCK;

EID: 0029838767     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02044115     Document Type: Article

References (37)

1. Bradley EL III (1993) A clinically based classification system for acute pancreatitis. Arch Surg 128: 586-590
2. Marshall JB (1993) Acute pancreatitis. Arch Intern Med 153: 1185-1198
3. Löser C, Fölsch UR (1993) A concept of treatment in acute pancreatitis results of controlled trials, and future developments. Hepatogastroenterology 40: 569-573
4. Lembke B, Creutzfeldt W, Schleser S, Ebert R, Shaw C, Koop I (1987) Effect of the somatostatin analogue Sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion 36: 108-124
5. Szabo S, Usadel KH (1982) Cytoprotection-organoprotection by somatostatin: gastric and hepatic lesions. Experimentia 38: 254-256
6. Usadel KH, Kessler H, Rohr G, Kusterer K, Palitsch KD, Schwedes U. (1986) Cytoprotective properties of somatostatins. Klin Wochenschr 64 [Suppl 7]: 59-63
7. Jenkins SA, Baxter JN, Day DW, Al-Sumidaie AM, Leinster SJ, Shields R (1986) The effects of somatostatin and SMS 201-995 on experimentally-induced pancreatitis and endotoxinemia in rats and on monocyte activity in patients with cirrhosis and portal hypertension. Klin Wochenschr 64 [Suppl 7]: 100-106
8. Usadel KH, Überla KK, Leuschner U (1985) Treatment of acute pancreatitis with somatostatin: results of the multicenter double-blind trial (APTS-study). Dig Dis Sci 30: 992
9. Choi TK, Mok F, Zhan WH, Fan ST, Lai ECS, Wong J (1989) Somatostatin in the treatment of acute pancreatitis: a prospective randomized controlled trial. Gut 30: 223-227
10. D'Amico D, Favia G, Biasiato R, Casaccia M, Falcone F, Fersini M, Marrano D, Neapolitano F, Oliviero S, Rodolico A (1990) The use of somatostatin in acute pancreatitis results of a multicenter trial. Hepatogastroenterology 37: 92-98
11. Gjorup I, Roikjaer O, Anderson B, Burcharth F, Hovendal C, Pedersen SA, Christiansen P, Wara P, Andersen JC, Balslev I, Jepsen J, Rokkjaer M (1992) A double-blinded multicenter trial of somatostatin in the treatment of acute pancreatitis. J Am Coll Surg 175: 397-400
12. Beechy-Newman N (1993) Controlled trial of high-dose octreotide in treatment of acute pancreatitis. Dig Dis Sci 38: 644-647
13. Binder M, Uhl W, Friess, Malfertheiner P, Büchler MW (1994) Octreotide in the treatment of acute pancreatitis: results of a unicenter prospective trial with three different octreotide dosages. Digestion 55 [Suppl 1]: 20-23
14. Steinberg WM, Schlesselman SE (1987) Treatment of acute pancreatitis. Gastroenterology 93: 1420-1427
15. Trede M, Carter DC (eds) (1993) Surgery of the pancreas. Churchill Livingstone, Edinburgh, London, New York
16. Beger HG, Büchler M (eds) (1987) Acute pancreatitis. Springer, Berlin, Heidelberg, New York
17. Ranson JHC, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC (1974) Prognostic signs and the role of operative management in acute pancreatitis. J Am Coll Surg 139: 69-81
18. Blamey SL, Imrie CW, O'Neill J, Gilmour WH, Carter DC (1984) Prognostic factors in acute pancreatitis. Gut 25: 1340-1346
19. Wilson C, Heath DI, Imrie CW (1990) Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 77: 1260-1264
20. Balthazar EJ, Ranson JHC, Naidich DP, Megibow AJ, Caccavale R, Cooper MM (1990) Acute pancreatitis: prognostic value of CT. Radiology 156: 767-772
21. Schölmerich J, Heinisch A, Leser HG (1993) Diagnostic approach to acute pancreatitis: diagnosis, assessment of etiology and prognosis. Hepatogastroenterology 40: 531-537
22. Larvin M, McMahon MJ (1989) APACHE II score for assessment and monitoring of acute pancreatitis. Lancet II 201-205
23. Mayer DA, McMahon MJ, Corfield AP, Cooper MJ, Williamson RCN, Dickson AP, Shearer MG, Imrie CM (1985) Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis. N Engl J Med 312: 399-404
24. Büchler M, Malfertheiner P, Uhl W, Schölmerich J, Stöckmann F, Adler G, Gaus W, Beger HG, and the German Pancreatitis Study Group (1993) Gabexate mesilate in human acute pancreatitis. Gastroenterology 104: 1165-1170
25. Medical Research Council Multicentre Trial (1980) Morbidity of acute pancreatitis: the effect of aprotinin and glucagon. Gut 21: 334-339
26. Fan ST, Lai ECS, Mok FPT, Lo CM, Zheng SS, Wong J. (1993) Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med 328: 228-232
27. Leese T, Holliday M, Heath D, Hall AW, Bell PRF (1987) Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis. Br J Surg 74: 907-911
28. Niederau C, Heise JW, Lüthen R, Becker H (1994) Systemische Komplikationen bei akuter Pankreatitis. Med Klin 89 [suppl 1]: 89
29. Carballo F, Dominguez E, Fernandez-Calvet L, Martinez-Pancorbo C, Garcia A, De la Morena J (1991) Is somatostatin useful in the treatment of acute pancreatitis? A meta- analysis. Digestion 49: 12-13
30. Kutz K, Nuesch E, Rosenthaler J (1986) Pharmacokinetics of SMS 201-995 in healthy subjects. Scand J Gastroenterol 21 [Suppl] 65-72
31. Kallivretakis N, Yotis A, del Pozo E (1985) Pharmacokinetics of SMS 201-995 in normal subjects and in patients with severe renal failure. Neuroendocrinol Lett 7: 92-95
32. Peffer F, Büsing M, Becker HD, Hopt UT (1993) Gibt es eine akute, exokrine Pankreasinsuffizienz? Langenbecks Arch Chir [Suppl] 227-231
33. Van Hagen PM, Krenning EP, Kwekkeboom DJ, Reubi JC, Anker-Lugtenburg PJ, Löwenberg B, Lamberts SWJ (1994) Somatostatin and the immune and haematopoietic system: a review. Eur J Clin Invest 24: 91-99
34. Dal Nogare AR (1989) Southwestern Internal Medicine Conference: adult respiratory distress syndrome. Am J Med Sci 298: 413-430
35. Bellomo R (1992) The cytokine network in critically ill. Anaesth Intensive Care 20: 288-302
36. Balibrea-Cantero JL, Arias-Diaz J, Garcia C, Torres-Melero J, Simon C, Rodriguez JM, Vara E. (1994) Effect of pentoxifylline on the inhibition of surfactant synthesis induced by TNF-alpha in human type II pneumocytes. Am J Respir Crit Care Med 149: 699-706
37. Murray JF, Matthay MA, Luce JM, Flick MR (1988) An expanded definition of the adult respiratory distress syndrome. Amer Rev resp Dis 132: 720-726